Lucid Diagnostics (LUCD) Cash from Operations (2020 - 2026)
Lucid Diagnostics (LUCD) posted Cash from Operations of 12101000.0 for Q1 2026, up 3.85% on a QoQ basis from 12585000.0 in Q4 2025, and up 2.92% year-over-year from 11757655.7 in Q1 2025.
Lucid Diagnostics (LUCD) Cash from Operations (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Cash from Operations history runs 7 years deep, the most recent figure standing at 12101000.0 for Q1 2026.
- Quarterly Cash from Operations rose 2.92% year-over-year to 12101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 46121000.0 (down 4.84% YoY) and the FY2025 annual result came in at 46485000.0, down 5.31% from the prior year.
- Cash from Operations was 12101000.0 for Q1 2026 at Lucid Diagnostics, up from 12585000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4258000.0 in Q4 2022 and bottomed at 13305000.0 in Q2 2022.
- A 5-year average of 9719294.12 and a median of 10175000.0 in 2024 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 56.89% in 2022, while the deepest fall reached 479.99% in 2022.
- Lucid Diagnostics' Cash from Operations stood at 4258000.0 in 2022, then sank by 134.36% to 9979000.0 in 2023, then grew by 1.08% to 9871000.0 in 2024, then retreated by 27.49% to 12585000.0 in 2025, then gained by 3.85% to 12101000.0 in 2026.
- Business Quant data shows LUCD's Cash from Operations at 12101000.0 in Q1 2026, 12585000.0 in Q4 2025, and 10886000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 525.60 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 290.00 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Lucid Diagnostics | 130.36 Mn | 102.48 Mn | -325,000.00 | -12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.10 Mn |
| Mar 31, 2026 | -12.10 Mn |
| Dec 31, 2025 | -12.59 Mn |
| Dec 31, 2025 | -12.59 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Jun 30, 2025 | -10.55 Mn |
| Jun 30, 2025 | -10.55 Mn |
| Mar 31, 2025 | -12.47 Mn |
| Mar 31, 2025 | -12.47 Mn |
| Dec 31, 2024 | -9.87 Mn |
| Dec 31, 2024 | -9.87 Mn |
| Sep 30, 2024 | -10.18 Mn |
| Sep 30, 2024 | -10.18 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Mar 31, 2024 | -12.61 Mn |
| Mar 31, 2024 | -12.61 Mn |
| Dec 31, 2023 | -9.98 Mn |
| Dec 31, 2023 | -9.98 Mn |